Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For Voclosporin – RTT News
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinRTT NewsThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six m…
